Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Journal of Hepatology|July 13, 2014
Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®)Thierry Poynard, Julien Vergniol, Yen Ngo, et al.
BMC Gastroenterology|November 14, 2006
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver diseaseThierry Poynard, Vlad Ratziu, Frederic Charlotte, et al.
Plos One|March 21, 2012
Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient dataThierry Poynard, Guillaume Lassailly, Emmanuel Diaz, et al.
The American Journal of Gastroenterology|September 1, 2005
Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infectionThierry Poynard, Fabien Zoulim, Vlad Ratziu, et al.
BMC Gastroenterology|March 1, 2006
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver diseaseVlad Ratziu, Julien Massard, Frederic Charlotte, et al.
Plos One|October 6, 2016
Real-Time Shear Wave versus Transient Elastography for Predicting Fibrosis: Applicability, and Impact of Inflammation and Steatosis. A Non-Invasive ComparisonThierry Poynard, Tam Pham, Hugo Perazzo, et al.
Hepatology (Baltimore, Md.)|December 5, 2008
Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver diseaseSylvie Naveau, Guillaume Gaudé, Amani Asnacios, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 1, 2020
Transportation and handling of blood samples prior to ammonia measurement in the real life of a large university hospitalFrançoise Imbert-Bismut, Pierre-Emeric Payet, Jamal Alfaisal, et al.
BMC Gastroenterology|October 17, 2007
Meta-analyses of FibroTest diagnostic value in chronic liver diseaseThierry Poynard, Rachel Morra, Philippe Halfon, et al.
Journal of Hepatology|April 4, 2006
The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver diseaseDominique Thabut, Sylvie Naveau, Frederic Charlotte, et al.
Pageof 8